As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL
Measurable weight loss typically begins in weeks 24, with the most significant losses occurring between months 3 and 9 as the dose reaches therapeutic levels
It is particularly relevant for patients with widespread plaques or psoriatic arthritis where systemic immune modulation is desirable
Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G
This coenzyme can support mental health, enhance muscle recovery, improve energy levels, and regulate blood sugar